National Health Investors (NYSE:NHI) Lowered to “Strong Sell” Rating by Zacks Research

Zacks Research cut shares of National Health Investors (NYSE:NHI) from a hold rating to a strong sell rating in a report released on Thursday morning,Zacks.com reports.

NHI has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft decreased their target price on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research report on Thursday. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Wells Fargo & Company dropped their price objective on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. BMO Capital Markets reduced their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $94.00 target price on shares of National Health Investors in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, National Health Investors has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Stock Performance

NHI stock opened at $77.58 on Thursday. The firm has a 50 day simple moving average of $74.89 and a 200 day simple moving average of $79.64. National Health Investors has a 52 week low of $67.94 and a 52 week high of $91.38. The stock has a market cap of $3.76 billion, a P/E ratio of 25.02, a P/E/G ratio of 4.15 and a beta of 0.52. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The company had revenue of $115.13 million during the quarter, compared to analyst estimates of $70.22 million. During the same period last year, the company posted $1.15 earnings per share. The company’s revenue was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Research analysts anticipate that National Health Investors will post 4.87 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.7%. National Health Investors’s dividend payout ratio is currently 118.71%.

Insider Buying and Selling at National Health Investors

In related news, Director Robert A. Mccabe, Jr. acquired 890 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, with a total value of $63,768.50. Following the completion of the purchase, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were acquired at an average price of $68.84 per share, with a total value of $103,260.00. Following the completion of the acquisition, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by company insiders.

Institutional Trading of National Health Investors

A number of hedge funds have recently bought and sold shares of the business. Militia Capital Management LLC purchased a new stake in National Health Investors in the first quarter worth $2,458,000. NewEdge Advisors LLC grew its stake in National Health Investors by 18.1% in the 1st quarter. NewEdge Advisors LLC now owns 12,046 shares of the real estate investment trust’s stock valued at $974,000 after buying an additional 1,844 shares in the last quarter. Bank of America Corp DE raised its holdings in National Health Investors by 20.0% during the 1st quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust’s stock valued at $80,278,000 after acquiring an additional 165,467 shares during the period. Janus Henderson Group PLC lifted its position in shares of National Health Investors by 14.9% during the first quarter. Janus Henderson Group PLC now owns 22,409 shares of the real estate investment trust’s stock worth $1,812,000 after acquiring an additional 2,900 shares in the last quarter. Finally, Amundi boosted its holdings in shares of National Health Investors by 5.2% in the first quarter. Amundi now owns 24,866 shares of the real estate investment trust’s stock worth $2,011,000 after acquiring an additional 1,225 shares during the period. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.